Philip Vickers
Direktor/Vorstandsmitglied bei AVROBIO, INC.
Vermögen: 5 688 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Erik Ostrowski | M | 51 | 5 Jahre | |
| Mark Foley | M | 58 | 7 Jahre | |
| Ian Clark | M | 62 | 7 Jahre | |
| Philip Donenberg | M | 63 | 6 Jahre | |
| Azadeh Golipour | M | - | 8 Jahre | |
| John Pribis | M | - |
Solu Therapeutics
 Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | - |
| Dwight Moxie | M | 48 | 4 Jahre | |
| Christian Nolet | M | 67 | 5 Jahre | |
| Vladimir Coric | M | 53 | 1 Jahre | |
| Tobin Schilke | M | 49 | 6 Jahre | |
| Christopher Paige | M | 71 | 8 Jahre | |
| Olivia Ware | F | 67 | 3 Jahre | |
| Steven Avruch | M | 63 | 5 Jahre | |
| Carey Kolaja | F | 51 | 3 Jahre | |
| Brandon Turunen | M | - |
Solu Therapeutics
Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | - |
| Jerel Davis | M | 47 |
Northern Biologics, Inc.
 Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada.
Northern Mosaic LP
 Northern Mosaic LP Miscellaneous Commercial ServicesCommercial Services Northern Mosaic LP provides biotechnology technology services. The company is headquartered in Toronto, Canada. | 6 Jahre |
| Annalisa Jenkins | M | 58 | 6 Jahre | |
| Julian Gangolli | M | 66 | 8 Jahre | |
| Jill Beraud | F | 63 | 5 Jahre | |
| Bruce Booth | M | 49 | 8 Jahre | |
| Gail Farfel | M | 60 | 4 Jahre | |
| Bradly G. Wouters | M | - |
Northern Mosaic LP
Northern Mosaic LP Miscellaneous Commercial ServicesCommercial Services Northern Mosaic LP provides biotechnology technology services. The company is headquartered in Toronto, Canada. | - |
| Scott Gottesman | M | - | - | |
| Kirsten Dupuis | F | - | 8 Jahre | |
| Peter Hutt | M | 89 |
Solu Therapeutics
Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | - |
| Essra Ridha | M | 41 | 3 Jahre | |
| Satoshi Konagai | M | - |
Solu Therapeutics
Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | - |
| John Hamer | M | 66 |
Solu Therapeutics
Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | - |
| Enda Moran | M | - |
Northern Biologics, Inc.
Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | 6 Jahre |
| Christoph H. Westphal | M | 56 |
Solu Therapeutics
Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | - |
| Bradley Bolzon | M | 64 |
Northern Mosaic LP
Northern Mosaic LP Miscellaneous Commercial ServicesCommercial Services Northern Mosaic LP provides biotechnology technology services. The company is headquartered in Toronto, Canada. | - |
| Leslie Waltke | F | - | 12 Jahre | |
| Conor Gallagher | M | - | 6 Jahre | |
| Joan Seoane Suarez | M | - |
Northern Mosaic LP
Northern Mosaic LP Miscellaneous Commercial ServicesCommercial Services Northern Mosaic LP provides biotechnology technology services. The company is headquartered in Toronto, Canada. | - |
| Omar Khalil | M | - |
Solu Therapeutics
Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | 1 Jahre |
| David Hollander | M | 50 | 2 Jahre | |
| Anita Treohan | F | - | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| L. Daniel Browne | M | 62 | 20 Jahre | |
| Graham Hetherington | M | 65 | 6 Jahre | |
| Geoff MacKay | M | 57 | 8 Jahre | |
| Scott Applebaum | M | 57 | 2 Jahre | |
| Kim Warren | M | - | 5 Jahre | |
| Dustin Sjuts | M | 45 | 6 Jahre | |
| James Bowling | M | 56 | 10 Jahre | |
| Susan Kilsby | F | 65 | 8 Jahre | |
| Cyril Allouche | M | 52 | 2 Jahre | |
| Angus Russell | M | 68 | 14 Jahre | |
| Aubrey Rankin | M | - | 2 Jahre | |
| Jacob M. Waugh | M | 53 | 16 Jahre | |
| Douglas Kerr | M | 57 |
Faze Medicines, Inc. /MA)
 Faze Medicines, Inc. /MA) Miscellaneous Commercial ServicesCommercial Services Faze Medicines, Inc. provides medical services. The company is headquartered in San Francisco, CA. | 5 Jahre |
| Christopher Mason | M | 66 | 7 Jahre | |
| S. Mathew | F | 68 | 4 Jahre | |
| Christoph Brackmann | M | - | - | |
| William R. Mordan | M | 54 | 4 Jahre | |
| Dominic Blakemore | M | 54 | 4 Jahre | |
| David Altarac | M | 63 | - | |
| Caryn McDowell | F | 54 | - | |
| Ludovic Robin | M | - | 8 Jahre | |
| Jeanie D. Herbert | F | - | 6 Jahre | |
| Deanna M. Petersen | F | 62 | 14 Jahre | |
| Ian Karp | M | - | 5 Jahre | |
| Phyllis Gardner | M | 73 | 15 Jahre | |
| Matthew Emmens | M | 72 | 11 Jahre | |
| Gail Fosler | F | 76 | 3 Jahre | |
| Albert P. L. Stroucken | M | 76 | 3 Jahre | |
| Mark Prygocki | M | 58 | 3 Jahre | |
| Steven Gillis | M | 71 | 7 Jahre | |
| David Stout | M | 69 | 6 Jahre | |
| Lauren Silvernail | F | 65 | 5 Jahre | |
| Ronald Eastman | M | 71 | 8 Jahre | |
| Robert F. Byrnes | M | 79 | 17 Jahre | |
| David John Kappler | M | 76 | 12 Jahre | |
| James Walter Glasheen | M | 56 | 12 Jahre | |
| Flemming Ørnskov | M | 66 | 6 Jahre | |
| Abhay Joshi | M | 61 | 7 Jahre | |
| Sotirios G. Stergiopoulos | M | 52 | - | |
| Ben Putman | M | - | 1 Jahre | |
| Barry M. Deutsch | M | 61 | 1 Jahre | |
| Miguel Coego Rios | M | - | 8 Jahre | |
| Susanne Fors | F | - | 1 Jahre | |
| Taryn Conway | F | - | 3 Jahre | |
| Debra Silberg | M | - | - | |
| Gisele Dion | F | 57 | 3 Jahre | |
| Ann Powell | F | 58 | 4 Jahre | |
| Daryl DeKarske | M | - | 7 Jahre | |
| Matthew Walker | M | 60 | - | |
| Nawal Ouzren | F | 45 | 1 Jahre | |
| Thomas P. Mcdonnell | M | 52 | 2 Jahre | |
| Roman Rubio | M | 53 | 5 Jahre | |
| Iain Ward | M | - | 8 Jahre | |
| Perry Sternberg | M | 55 | 6 Jahre | |
| Arthur Tzianabos | M | 60 | 8 Jahre | |
| Sheila E. Stranks | F | - | 13 Jahre | |
| Gwendolyn Fisher | F | - | 96 Jahre | |
| Michele Galen | F | 67 | 1 Jahre | |
| David Colpman | M | 62 | 15 Jahre | |
| Andrea Hunt | F | 64 | 1 Jahre | |
| Erica Bazerkanian | F | - | 4 Jahre | |
| Jeffrey Leiden | M | 68 | 6 Jahre | |
| Bill Mordan | M | - | 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 55 | 55,00% |
| Irland | 43 | 43,00% |
| Kanada | 5 | 5,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Philip Vickers
- Persönliches Netzwerk
